The Chinese Biopharmaceutical Association-USA (CBA), one of the largest Chinese American professional associations in the United States, held its annual meeting at Suzhou International Expo Centre in SIP on June 28, and concurrently set up the CBA-China in the industrial park.
It was the first time that a CBA annual meeting was held in Suzhou, and other four sessions will be held in the city for four consecutive years.
This year’s event consisted of the main forum and 26 sub-forums focused on macromolecule and small molecule drugs, antibody-drug conjugates (ADCs), vaccines and other therapies, along with a series of alumni meetings and events for enterprises.
The CBA-China is dedicated to serving as a bridge between SIP and global biomedicine communities to promote sharing of resources and enhance communication and exchanges between related professionals and organizations.
Source: Yin Li Bo, June 28, 2024
